CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
75.90
+0.04 (0.05%)
Sep 2, 2026, 10:07 AM EDT - Market open
CG Oncology Market Cap
CG Oncology has a market cap or net worth of $6.73 billion as of September 2, 2026. Its market cap has increased by 228.99% in one year.
Market Cap
6.73B
Enterprise Value
5.71B
1-Year Change
228.99%
Ranking
Category
Stock Price
$75.90
ChartMarket Cap Chart
Since the IPO on January 25, 2024, CG Oncology's market cap has increased from $1.21B to $6.73B, an increase of 457.78%. That is a compound annual growth rate of 93.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 6.73B | 100.87% |
| Dec 31, 2025 | 3.35B | 53.40% |
| Dec 31, 2024 | 2.18B | 81.02% |
| Jan 25, 2024 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rhythm Pharmaceuticals | 7.38B |
| Caris Life Sciences | 7.24B |
| Scholar Rock Holding | 7.04B |
| Mirum Pharmaceuticals | 6.33B |
| Erasca | 6.31B |
| Travere Therapeutics | 6.19B |
| Belite Bio | 6.11B |
| Oruka Therapeutics | 6.03B |